Strike Pharma

About:

Strike Pharma is using the company’s proprietary Adaptable Drug Affinity Conjugate (ADAC).

Website: http://www.strikepharma.com/

Top Investors: Almi Invest, EIR Ventures, Flerie Invest

Description:

Strike Pharma is using the company’s proprietary Adaptable Drug Affinity Conjugate (ADAC). The company employs an antibody-based technique based on the genetic profile of each patient's tumor that destroys tumor cells while leaving other normal cells alone in the body. The company offers patients a low-cost, effective medication while minimizing the danger of unwanted effects.